CIK 0001429260 · Non-accelerated filer<br>Smaller reporting company
Fortress Biotech, Inc.
Sign in to watch- Ticker
- FBIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 205157386
- Phone
- 781-652-4500
- Business address
- 1111 KANE CONCOURSE, SUITE 301, BAY HARBOR ISLANDS, FL, 33154
- Former names
- Fortress Biotech, Inc., CORONADO BIOSCIENCES INC
Securities
- FBIO Common Stock Nasdaq
- FBIOP 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock Nasdaq
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-01-01 | LOBELL J JAY Director | Grant or award | +100,000 | 1,136,000 | ||
| 2021-01-01 | Klein Dov Director | Grant or award | +100,000 | 655,000 | ||
| 2021-01-01 | Hoenlein Malcolm Director | Grant or award | +50,000 | 435,000 | ||
| 2020-12-01 | ROSENWALD LINDSAY A MD PRESIDENT, CEO & CHAIRMAN | Grant or award | +1,250 | $2.34 | $3K | 9,376,700 |
| 2020-06-01 | ROSENWALD LINDSAY A MD PRESIDENT, CEO & CHAIRMAN | Grant or award | +1,602 | $1.69 | $3K | 9,375,450 |
Page 6 of 6 · 105 trades